Senescent cells: New target for an old treatment?
Many genotoxic chemotherapies have debilitating side effects and induce cellular senescence in normal tissues. Senescent cells acquire a pro-inflammatory phenotype which contributes to local and systemic inflammation. Eliminating senescent cells reduce several short- and long-term effects of the dru...
Main Author: | Marco Demaria |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-05-01
|
Series: | Molecular & Cellular Oncology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/23723556.2017.1299666 |
Similar Items
-
Senescent Cells: A Therapeutic Target in Cardiovascular Diseases
by: Masayoshi Suda, et al.
Published: (2023-05-01) -
Targeting senescent cells in translational medicine
by: Marta Paez‐Ribes, et al.
Published: (2019-12-01) -
The Emerging Role of Senotherapy in Cancer: A Comprehensive Review
by: Sarubala Malayaperumal, et al.
Published: (2023-07-01) -
Editorial: Cellular senescence in physiology and pathophysiology
by: Mustafa Ark, et al.
Published: (2023-03-01) -
Cellular senescence in asthma: from pathogenesis to therapeutic challenges
by: Rongjun Wan, et al.
Published: (2023-08-01)